The peroxidative DNA damage and apoptosis in methamphetamine- treated rat brain by Tokunaga, Itsuo et al.
INTRODUCTION
Acute use of methamphetamine (MATH) can re-
sult in toxic effects on the central nervous systems.
Long term MATH use also adversely affects these
systems, resulting in problems such as chronic psy-
chosis, and paranoia (1, 2, 4, 5). The potential for
serious and medically harmful effects are so sig-
nificant that animal models must be used to study
the more extreme adverse health effects caused by
high MATH use (2, 3). Research into the influence
of METH on the central nervous system (CNS) has
been performed (4 - 6). Especially, there have been
many reports describing changes in neurotransmit-
ters, such as dopamine and serotonin (7 -10). Re-
cently, the formation of reactive oxygen species
(ROS) promoting the CNS neurotoxicity induced by
METH has been investigated. In particular, eleva-
tions of lipid oxidation products in the brain were
reported (11 - 13). However, oxidative DNA damage
has scarcely been reported. We have been studying
about peroxidative damage in rat organs induced
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by METH (14).
In this study, in the METH-administered rat
brain, we histopathologically observed peroxida-
tively damaged DNA, 8 -OH-dG and in situ apop-
tosis to investigate peroxidative DNA damage.
MATERIALS AND METHODS
2.1. Animal treatment
Nine- week- old male Wistar rats weighing about
250 g were obtained from Japan SLC (Shizuoka,
Japan) and maintained on a 12 hr light - 12 hr dark
schedule with food and water available ad libitum.
Methamphetamine hydrochloride (METH) (Phi-
lopon) (Dainihon-Sumitomo, Japan) was diluted in
saline. The concentration of METH was adopted as
the abuse dose, not a lethal dose (14).
Total 48 rats were used for this study, following
protocols. All animal experiments were carried out in
accordance with the principles of laboratory animal
care (NIH publication NO. 85 - 23, revised 1985).
2.1.1. Group I : Single administration group ;
Rats (n=6) were injected with 50 mg/kg (i.p.)
of METH. The METH dose was near LD50. Con-
trol rats (n=6) in separate chambers were injected
with saline on the same schedule as the METH
group.
To observe the acute influence of METH, animals
were asphyxiated with CO2 1 hr after treatment.
2.1.2. Group II : Repeated administration group ;
Rats (n=6) were injected with 10 mg/kg/day
(i.p.) of METH for 5 days. A METH dose that would
induce chronic stress was selected. Control rats
(n=6) in separate chambers were injected with sa-
line on the same schedule as the METH group.
To exclude the acute influence of METH, animals
were asphyxiated with CO2 24 hr after the last treat-
ment.
2.2. Histopathological examination
For immunohistochemical analysis, METH treated
rats (n=6) and control rats (n=6) were perfused
through the ascending aorta with 0.01 M phosphate
buffered saline (PBS, pH 7.2) followed by 4 % para-
formaldehyde in 0.1 M phosphate buffer (pH 7.4)
after asphyxiation with CO2. The brain was removed
and post - fixed in the same fixative overnight at
4. Brains were dissected out and each brain was
cut into 2 mm slices. Tissue was then embedded in
paraffin, and 5 μm- thick sections were cut.
2.2.1 Immunohistochemical staining for 8-OH-dG
After deparaffinization, the section were treated
with 0.3 % H2O2 in methanol for 30 min for inactiva-
tion of endogenous peroxidase and then incubated
in blocking solution for 10 min. For immunostain-
ing, 8 -hydroxy - 2’- deoxyguanosine (8 -OH-dG),
RNase treatment, 250 μg/ml RNase for 1hr at 37,
accompanied blocking. Sections were incubated with
diluted anti - 8 -OH-dG (5 μg/ml, JICA, Japan).Im-
munostaining was carried out using a HISTOFINE
SAB-PO(MULTI) kit (Nichirei, Japan) following
the manufacturer’s instructions. Immunostaining
was visualized by incubating with 0.02 % 3, 3’ -
diaminobenzidine (DAB) and 0.03 % hydrogen per-
oxide in PBS.
To confirm that 8 -OH-dG immunopositive cells
are neurons, additional immunostaining was per-
formed with anti - human neuron specific enolase
(NSE, Dako Cytomation, Japan). After 8 -OH-dG
immunostaining, the sections were pretreated by
autoclave (121, 15 min) and then double stained
by incubating overnight at 4with anti -NSE. Im-
munostaining was carried out using an ENVISION/
AP Kit (Dako Cytomation, Japan) following the
manufacturer’s instructions. Immunostaining was
visualized by incubating with Fuchsin substrate -
chromogen kit (Dako Cytomation, Japan).
2.2.2. In situ apoptosis detection
In situ apoptosis detection was carried out using
an ApopTag -kit (INTERGEN, USA) following the
manufacturer’s instructions.
2.2.3. Semi-quantitative analysis of 8-OH-dG im-
munopositivity and in situ apoptosis
Neurotoxicity induced by METH was occurred
in selective vulnerability region such as, nucleus
accumbens. So, we observed comparatively each
part of cerebrum, such as cortex, hippocampus,
striatum, and nucleus accumbens, respectively.
The number of immunopositive neurons, were
counted in two fields under100 magnification in
cerebral cortex and striatum, and in all fields un-
der100 magnification in the hippocampus. Also,
the number of immunopositive nerve cells was
counted in two fields under400 magnification in
the nucleus accumben, respectively. Total number
of positive neurons in each field was compared be-
tween the control and METH group, and the per-
cent of control was calculated. This quantitative
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analysis was performed by someone without prior
knowledge of the experimental procedure.
Statistical analysis was performed by parametric
t - test, and a p - value less than 0.05 was considered
significant.
All animal experiments in the present study were
approved by The Committee for the Care and Use
of Animals in the University of Tokushima Gradu-
ate School and performed by the Institutional Ani-
mal Care and Oversight Committee according to
established guideline principles.
RESULTS
Results of semi -quantitative analysis of 8 -OH-dG
immunopositivity and in situ apoptosis are summa-
rized as the percent of control in Table 1. Almost
all 8 -OH-dG - immunopositive cells also showed im-
munoreactivity of neuron specific enolase (Fig. 1).
So, it was considered that peroxidative DNA dam-
age was occurred in neurons mainly.
3.1. Group I : Single administration group
In group I, there were some individual rats dem-
onstrating a slight spasmus as a symptom during
the 1 -hr experimental period (14).
Number of 8 -OH-dG - immunopositive cells were
54.34.7 in cerebral cortex, 36.323.2 in hippocam-
pus, 67.78.4 in striatum and 33.314.2 in nucleus
accumbens of the control rats, respectively. Im-
munoreactivity of 8 -OH-dG, only in the nucleus
accumbens, was significantly increased, more than
two times, in METH- treated rats (number of im-
munopositive cells ; 73.718.6), against the control
(33.314.2)(p0.05). On in situ apoptosis detection,
only several apoptotic cells were observed, such as
5.73.8 in cerebral cortex, 4.01.7 in hippocampus,
11.31.5 in striatum and 3.72.9 in nucleus ac-
cumbens of the control rats, respectively. But the
number of apoptotic cells was significantly increased
in almost all regions, 35.316.2 in cerebral cortex,
57.012.4 in striatum and 62.311.1 in nucleus ac-
cumbens, respectively (p0.05) (Fig. 2). In the hip-





control METH control METH control METH control METH
Group I
8 -OH-dG 99.7 127.7 100.1 127.6 100.0 118.7 100.1 *221.2
       
5.3 13.8 36.8 59.3 7.1 7.1 24.6 32.2
apoptosis 99.4 *619.9 100.0 1233.3 102.1 *504.4 99.1 *1684.7
       
38.3 163.7 25.0 698.9 7.7 63.8 45.0 174.0
Group II
8 -OH-dG 100.1 115.6 100.0 106.8 100.0 98.0 99.9 * 163.1
       
9.7 21.4 6.3 2.9 6.3 11.6 9.7 19.5
apoptosis 100.0 120.0 100.0 145.8 100.2 74.6 100.5 105.0
       
8.3 15.1 44.3 79.2 14.2 18.2 25.4 40.6
* ; p0.05
a b
Fig. 2 In situ apoptosis detection in nucleus accumbens
(Group I)
a : control, b : METH treated (200)
Fig. 1 Double staining of 8 -OH-dG and human NSE in nu-
cleus accumben in METH- treated rat (Group II)
; neurons shows NSE-positive and 8 -OH-dG negative
; neurons both NSE and 8 -OH-dG positive
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pocampus, the number of apoptotic cells did not
show the statistic significance against the control
(4.01.7) (p= 0.18), because the individual variation
was large (49.348.4) (Table 1).
3.2. Group II : Repeated administration group
In group II, body weight had decreased signifi-
cantly by the fifth day (p0.05) (data not shown)
(14). It was suspected that systemic toxic effects
of METH had appeared.
Number of 8 -OH-dG - immunopositive cells were
66.311.2 in cerebral cortex, 73.07.9 in hippocam-
pus, 33.03.6 in striatum and 32.75.5 in nucleus
accumbens of the control rats, respectively. In the
METH- treated rats, the nucleus accumbens only
showed significant increases in 8 -OH-dG - im-
munopositive cells (53.311.1)(p0.05)(Table 1).
On in situ apoptosis detection of the control rats,
relative many apoptotic cells, against the control of
group I, were observed, such as 35.05.0 in cere-
bral cortex, 16.01.7 in hippocampus, 11.31.5 in
striatum and 3.72.9 in nucleus accumbens, respec-
tively. However, in situ apoptosis detection did not
show any remarkable differences in any region in
the METH- treated rats (p0.05) (Table 1).
DISCUSSION
In METH- induced neurotoxicity, oxidative stress
plays an important role. It was reported that METH
administration induced elevations of lipid and pro-
tein oxidative markers in the brain (11 - 13). Oxida-
tive damage differs according to the reactive oxy-
gen species produced and the surrounding envi-
ronment. In other radicals, peroxynitrite (ONOO -)
participates in oxidative damage of lipids and pro-
teins (15). In addition, the brain is a lipid - rich or-
gan. Therefore, peroxynitrite may be the main par-
ticipant in oxidative damage induced by METH in
the brain. The oxidative damage in the brain might
be the dominant site of lipid peroxidation. In previ-
ous our report, 4 -hydroxy - 2 -nonenal, marker of
lipid peroxidation, was enhanced in cerebral cor-
tex and nucleus accumbens of METH- treated rat
brain except hippocampus and striatum , immuno-
histochemically (16)
The hydroxyl - radical (OH) is a major damage -
causing free radical. While it is considered that the
hydroxyl - radical participates in oxidative DNA dam-
age, this radical has an extremely short life (17).
In our other study, SOD immunoreactivity was en-
hanced in cerebral and cerebellar cortex, such as
neurons and Purkinje cells in the METH group (16).
So, we observed the oxidative DNA damage in
METH- treated rat, immunohistopathologically. In
group I, immunoreactivity of 8 -OH-dG was only
enhanced in neurons of the nucleus accumben of
METH- treated rats. On in situ apoptosis detection,
positive findings were also enhanced in all exam-
ined parts compared to those in the control, though
there were no significant increases in 8 -OH-dG -
immunopositive neurons except in the nucleus ac-
cumben. In group II, the nucleus accumben also
showed enhanced 8 -OH-dG immunopositivity com-
pared to that in the control. There was no signifi-
cant difference in apoptosis between the control and
METH groups.
Based on our observations, it is considered that
METH induces oxidative DNA damage in the brain,
especially in the nucleus accumben. However, those
DNA damage might be caused differently between
acute and chronic administration. Then, repeated
administration of METH might accentuate the ac-
tive oxygen deletion system, such as SOD, which
might prevent the DNA damage (13).
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